Modern cataract surgery for radiation-induced cataracts in retinoblastoma Philippe Othenin-Girard, 2 Alessia Pica, 4 Raphaël Moeckli, 5 Daniel F Schorderet, 3, 6 Francis L Munier 2, 3 ABSTRACT Background Surgery of radiation-induced cataracts in children with retinoblastoma (RB) is a challenge as early intervention is weighted against the need to delay surgery until complete tumour control is obtained. Conclusions Modern cataract surgery, including clear cornea approach, lens aspiration with posterior capsulotomy, anterior vitrectomy and IOL implantation is a safe procedure for radiation-induced cataract as long as RB is controlled. The visual prognosis is limited by initial tumour involvement of the macula and by corneal complications of radiotherapy. We recommend a minimal interval of 9 months between completion of treatment of retinoblastoma and cataract surgery.
INTRODUCTION
Because of its radiosensitive nature, retinoblastoma (RB) has been treated with first-line external beam radiotherapy (EBR) with a total dose of 45e50 Gray. 1 Due to the devastating side-effects on the bony orbit 2 and the risk to develop osteosarcoma, 3 the trend has been to move away from radiotherapy. 4 Chemoreduction, focal therapy and brachytherapy with 106 ruthenium or 125 iodine have proven excellent for tumour control restricting the indication of EBR as second-line treatment or as salvage treatment. 5e10 The lens is the most sensitive ocular structure to radiotherapy and a single dose as low as 2 Gy can cause cataract. 11 Posterior subcapsular cataract occurs in 22e87% of eyes after EBR 11 12 and in 9.7e31% after brachytherapy 7 8 within a 1e3-year period. The incidence of cataract can be reduced with the use of the lens sparing radiation technique. 1 13 Paediatric cataract surgery has benefited from the modern technical improvements in surgery and intraocular lens implantation. The timing of intervention for cataract in infants is important because children go through a visually sensitive period and the success of visual rehabilitation depends on early surgical intervention with effective amblyopia treatment. 14 15 Attempts to operate affected eyes before complete tumour regression carry the risk of spreading tumour. 16 The present study was motivated by the limited information in the literature as regard to the optimal timing and the expected outcome of modern cataract surgery in RB patients. We reviewed medical records of RB patients operated for radiation-induced cataract following EBR or brachytherapy between 1985 and 2008.
PATIENTS AND METHODS
This study was approved by the Swiss Federal Department of Health (authorisation # 035.0003e48) and did not require approval from the Ethical Committee of the University of Lausanne. The study follows the principles of the Declaration of Helsinki. We reviewed the medical records for all RB patients undergoing cataract surgery for radiation-induced cataract at the JulesGonin Eye Hospital between 1985 and 2008. Patients aged 14 years or under were selected. The data collected included sex; laterality of the disease; hereditary pattern; age at diagnosis; age at the time of surgery; Reese-Ellsworth 17 and International classification 18 of RB; the presence or absence of macular involvement; treatment modality received in addition to the radiotherapy; type of radiation given; interval from radiation to cataract diagnosis; interval from cataract diagnosis to cataract surgery; interval from last RB treatment to the cataract surgery; surgical approach; surgical technique of cataract; type of intraocular lens (IOL); peroperative and postoperative complications as well as duration of postoperative follow-up. Follow-up data included clarity of visual axis, state of tumour control, ocular preservation or enucleation, presence or absence of systemic metastasis as well as postoperative best-corrected visual acuity. Visual acuity was measured in children older than 2 y using Snellen charts.
All eyes except two were observed for a minimum 9-month period after the conclusion of all tumour treatments before considering cataract surgery. In the mentioned two eyes, because the cataract was significantly dense and prevented the delivery of scheduled treatment of active RB tumours, the surgery was performed 3 and 5 months after the last treatment for retinoblastoma.
Surgical technique
Complete ocular examination under general anaesthesia was performed before intraocular surgery and included keratometry, retinoscopy, Kowa hand-held retinal photograph (Kowa Company, Tokyo, Japan) or Retcam photographs (Clarity Medical Systems, Inc, Pleasanton, California, USA) and ultrasound axial length measurements (Otis Instruments, Inc, Bryan, Texas, USA). In eyes with macular involvement, axial length measurements of fellow eyes were made for IOL calculations. The surgical technique was either extra-capsular cataract extraction (ECCE) or phacoaspiration (Alcon Infiniti Vision System, Alcon, Inc, Hünenberg, Switzerland; Ophthalmic Small Incision Surgery System, Oertli Instruments, Switzerland) with or without intraocular lens implantation into the capsular bag. Posterior capsulorhexis was performed manually in patients under 5 y old to prevent visually threatening posterior capsule opacification inaccessible to YAG laser. Anterior vitrectomy was performed with the Alcon Infiniti Vision or the Ophthalmic Small Incision Surgery System. Foldable acrylic IOL was inserted through a 3.0 mm clear corneal entry and polymethyl methacrylate nonfoldable IOL through a 5.0 mm scleral entry when phacoaspiration was performed. When ECCE was performed, a limbal 10 mm incision was the rule. After surgery, patients used ofloxacin drops for 1 week and topical prednisolone for at least 1 month. Within 2 weeks after cataract removal, either spectacles or contact lenses were prescribed for aphakic cases. Amblyopia was treated with patching and monitored as warranted.
RESULTS
We identified 21 eyes of 20 patients with RB suffering from radiation-induced cataract. One patient was operated for bilateral radiation-induced cataract. Out of the 20 patients, 19 were sporadic and 1 familial. The median age at RB diagnosis was of 11 months (range 3e29).
Clinical features of patients are listed in table 1.
The median age at cataract surgery was of 4 y (range 2.75e14.33). The median interval from the end of irradiation to the first sign of cataract was of 16 months (range 8e69), while the median interval from the onset of cataract to the time of cataract surgery was of 11 months (range 4e143). The median interval between last treatment and cataract surgery was of 21.5 months (range 3e164 months).
The distribution of the modality of radiotherapy used in this study is presented in table 2. Table 3 summarises the techniques of cataract surgery and the types of IOLs used. Wound entry for the cataract surgery was limbal in 7seven eyes (33%), scleral in seven eyes (33%) and clear cornea in seven eyes (33%). There were no peroperative complications in any of the operated eyes. There was primary posterior capsulorhexis in 11 surgeries (52%), with anterior vitrectomy in 6 cases (28%). Vitreous fluid was collected and sent for cytopathological examination in three cases, which were free of tumour cells. Eighteen eyes (85%) did not suffer from any postoperative complications while there was one eye with glaucoma, one case with intraocular lens subluxation that was repositioned later and one eye that developed cystoid macular oedema 13 months after cataract surgery. This later complication was transient and responded well to topical antiinflammatory treatment and systemic dorzolamide; it occurred in an eye with preoperative severe actinic maculopathy. There was no case of postoperative retinal detachment. Table 4 presents postoperative best-corrected visual acuity at last follow-up visit. The macula was affected by the tumour in 7 eyes (35%) and not affected in 13 eyes (65%). The mean postoperative follow-up period was of 90669 months. All eyes had clear visual axis; however, seven eyes developed secondary cataract and needed either YAG capsulotomy (in six eyes) or pars plana capsulotomy (in one eye).
Radiation complications, such as retinopathy and maculopathy, occurred in 10 eyes while keratopathy occurred in 4 eyes. Tumour control was achieved in 18 eyes (86%) and 3 eyes (14%) had recurrences. The first case of recurrence occurred 12 months after cataract surgery; he had been operated 37 months after last RB treatment with phacoaspiration technique and posterior capsule preservation and he was successfully managed with local treatment, thermochemotherapy and transpupillary thermotherapy. The second recurrence case occurred 11 months after ECCE surgery with primary posterior capsulotomy, which took place only 3 months after last RB treatment because of the need to visualise the fundus; he was encleated because of the presence of RB seeds in the anterior chamber. The third recurrence occurred 7 months after clear cornea cataract surgery with posterior capsule preservation, which was performed 5 months after RB treatment completion for proper fundus monitoring. Enucleation had to be performed rapidly because of the presence of a novel mass not accessible to treatment. In total, three eyes were enucleated, two of them for tumour recurrence and the third one because of neovascular glaucoma. There was no systemic metastasis in any of the 20 patients.
DISCUSSION
We report a series of 21 paediatric RB patients with radioinduced cataract after EBR or brachytherapy, operated with two techniques of cataract surgery, phacoaspiration (61%) and ECCE (39%) and 90% IOL implantation, without significant surgical complications after a mean follow-up of 90 months. The majority of cases (52%) underwent posterior capsulotomy and about a third (28%) an anterior vitrectomy, and these procedures did not seem to influence the high tumour control rate of 86% (3/21 recurrences) obtained with the respect of a minimum interval of 9 months between last treatment for RB and cataract surgery. This study represents the third largest one in the field of radiation-induced cataract and the largest one using lens aspiration technique. In 1939, Reese reported the first surgical treatment of radiationinduced cataract using intracapsular cataract surgery. 19 The complications encountered were related to the excess residual cortex and not to difficulties with the eyes that received the radiotherapy. 19 In the present study, postoperative inflammation was moderate in children receiving radiation therapy. This was also noted by Portellos and Buckley in their 11 cases study and was attributed to the destruction by the radiotherapy of the antigenic lens proteins and cells. 20 In contrast with studies in which pars plana lensectomy was the predominant surgical technique performed, 21e24 we did not observe any case of postoperative retinal detachment. We report only one case of cystoid macular oedema, which occurred 13 months after cataract surgery in an eye of a 14-year-old child who had developed late radiationinduced maculopathy almost 6 y after EBR, which had resolved 1 y before cataract surgery. In contrast with the 31% rate of postoperative cystoid macular oedema and 19% rate of iridocyclitis in the study of Miller et al, 22 our low rate of postoperative complications is to be attributed to the safety of ECCE and, especially, of phacoaspiration when compared to pars plana lensectomy and to the lower inflammatory effect of any surgical approach anterior to the iris plane. Clear cornea incisions carry the advantage of offering a better visualisation of eventual tumour recurrence at the entry site, which is covered by conjunctiva in case of limbal or scleral incision. Preoperative actinic maculopathy may be a risk factor for the development of late postoperative cystoid macular oedema, although Miller et al 22 did not report on the delay between surgery and occurrence of cystoid macular oedema and did not mention any history of actinic maculopathy.
We observed only three cases of intraocular tumour recurrence and no case of tumour exteriorisation of metastasis. Different rates of recurrence are reported in similar studies 19e22 and several eventual causing or contributing factors have been evoked. First, the minimal interval between completion of RB treatment and cataract surgery differs in the largest studies. While we applied a security period of minimum 9 months, Brooks et al 21 22 who applied the longest interval, suggesting a correlation between the longer interval and the lower rate of recurrence. In the present study, one recurrent case was operated 37 months after RB treatment completion and only 3 and 5 months elapsed for the two other cases for the sake of proper monitoring of the tumour. This confirms the importance of adequate tumour control before any surgical intervention and the difficulty to weight the risk of surgery with an undiagnosed recurrence to the risk of delay of diagnosing a recurrence due to opaque lens with insufficient tumour visualisation. The second incriminated factor is the performance of posterior capsulotomy associated or not with anterior vitrectomy. Several authors 21 23 Because other large series included significantly less RB Reese-Ellsworth stage V, 21 22 24 our series tumour outcome is to be compared to the one of Miller et al 22 in which all patients were Reese-Ellsworth stage V. Although they did not report any tumour recurrence, their mean follow-up was shorter that the one we report (66 months compared to 90 months) and their rate of visually devastating complications was considerably higher. The ideal interval between last treatment for RB and cataract surgery and the need for preservation of the posterior capsule will still remain a matter of debate. We suggest a safety period of minimal 9 months between last RB treatment and cataract surgery and we do confirm the safety of posterior capsulotomy and anterior vitrectomy.
In the present series, the visual outcome was of 20/20 in a limited number of four cases and between 20/20 and 20/200 in nine cases, which is a satisfactory achievement. Amblyopia treatment was strictly performed whenever necessary and It is of importance to note that in our study both EBR and brachytherapy were included; all eyes except one underwent EBR and almost half cases underwent both EBR and brachytherapy. The safety of cataract surgery after brachytherapy has been highlighted and should prompt RB specialists to use this treatment modality more often and to prefer it to EBR whenever possible.
We recommend modern cataract surgery for radiation-induced cataract, which include clear cornea incision, phacoaspiration, IOL implantation with or without posterior capsulotomy, and anterior vitrectomy. RB has to be adequately controlled before surgery; although no definite timing can be determined, we do recommend a minimum interval of 9 months between the last treatment for RB and the cataract surgery. The visual prognosis is mainly limited by the initial tumour involvement of the macula and by ocular complications of the radiotherapy. Longterm safety of IOL implantation has still to be determined. Because life expectancy of RB children has considerably evolved with modern treatment of RB, visual outcome has become a major goal in RB management.
